España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Personalis
PSNL
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.34
-0.51
-13.25%
Last update: 12:50 PM
15 minutes delayed
Get Report
Comment
Personalis (PSNL) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Personalis (NASDAQ:PSNL) Stock
Personalis Stock (NASDAQ: PSNL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, July 11, 2024
Myriad Genetics And Personalis Announce Cross...
Benzinga Newsdesk
Wednesday, July 03, 2024
Personalis 13D Filing Shows Tempus AI Reporte...
Benzinga Newsdesk
Friday, June 21, 2024
Breaking Down Personalis: 4 Analysts Share Their Views
Benzinga Insights
Needham Reiterates Buy on Personalis, Maintai...
Benzinga Newsdesk
Tuesday, June 04, 2024
Personalis To Present NeXT Personal Ultra-Sen...
Benzinga Newsdesk
Monday, June 03, 2024
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Friday, May 31, 2024
Personalis Announces Tempus Begins Commercial...
Benzinga Newsdesk
Thursday, May 09, 2024
4 Analysts Have This To Say About Personalis
Benzinga Insights
Personalis shares are trading higher after th...
Benzinga Newsdesk
Needham Reiterates Buy on Personalis, Maintai...
Benzinga Newsdesk
Wednesday, May 08, 2024
Personalis Sees Q2 Revenue $19.5M-$20.5M vs $...
Benzinga Newsdesk
Personalis Q1 2024 GAAP EPS $(0.26) Beats $(0...
Benzinga Newsdesk
Tuesday, April 30, 2024
Lake Street Initiates Coverage On Personalis ...
Benzinga Newsdesk
Wednesday, April 17, 2024
Cathie Wood's Ark Laps Up $3.3M Worth Of Tesla As Stock Falls For 3rd Straight Session, Sheds Shares Of This Sports Betting Company
Shanthi Rexaline
Thursday, April 11, 2024
Needham Reiterates Buy on Personalis, Maintai...
Benzinga Newsdesk
Thursday, April 04, 2024
Cathie Wood's Ark Invest Buys More Shares Of This Meta Platforms Competitor
Benzinga Neuro
Friday, March 29, 2024
Cathie Wood's Ark Continues Tesla Stock Buying Spree, Acquires Over $14M Worth Of Shares Amid Dip
Benzinga Neuro
Tuesday, March 26, 2024
Personalis Announces Publication Validating N...
Benzinga Newsdesk
Thursday, March 21, 2024
Cathie Wood's Ark Invest Sells Another Tranche Of Block Shares, Even As Bitcoin Price Stages A Recovery
Benzinga Neuro
Wednesday, March 20, 2024
Cathie Wood's Ark Invest Isn't Done Selling Shares Of Jack Dorsey-Led Block Yet — Sheds $7.5M Worth of Stock As Bitcoin Price Drops
Benzinga Neuro
Friday, March 08, 2024
Cathie Wood Sells $13.15M Worth Of Coinbase Shares Amid Bitcoin Flirting With All-Time High Levels — Shops For Palantir Stock Instead
Benzinga Neuro
Wednesday, March 06, 2024
Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor
Thursday, February 29, 2024
Needham Maintains Buy on Personalis, Raises P...
Benzinga Newsdesk
Wednesday, February 28, 2024
Personalis Expects Total Company Revenue Of $...
Benzinga Newsdesk
Personalis: Q4 Earnings Insights
Benzinga Insights
Personalis Q4 2023 GAAP EPS $(0.54) Misses $(...
Benzinga Newsdesk
Earnings Scheduled For February 28, 2024
Benzinga Insights
Tuesday, January 30, 2024
Personalis And ClearNote Health Announce Part...
Benzinga Newsdesk
Tuesday, January 16, 2024
Personalis Announces Medicare Coverage For It...
Benzinga Newsdesk
Friday, January 05, 2024
Needham Reiterates Buy on Personalis, Maintai...
Benzinga Newsdesk
Personalis Reports Preliminary Q4 And FY23 Re...
Benzinga Newsdesk
Tuesday, December 26, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, December 04, 2023
Personalis Announces Workforce Reduction Impa...
Benzinga Newsdesk
Tuesday, November 28, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Personalis To Provide Warrants To Tempus To P...
Benzinga Newsdesk
Personalis, Tempus Enter Strategic Collaborat...
Benzinga Newsdesk
Tuesday, November 21, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, November 20, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Friday, November 17, 2023
Myriad Genetics Agrees To Market The Personal...
Benzinga Newsdesk
Wednesday, November 08, 2023
Personalis shares are trading higher after th...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Needham Maintains Buy on Personalis, Lowers P...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Personalis Sees Q4 Revenue $19M-$20M Vs $18.1...
Benzinga Newsdesk
Tuesday, November 07, 2023
Personalis: Q3 Earnings Insights
Benzinga Insights
Personalis Q3 EPS $(0.60) Misses $(0.53) Esti...
Benzinga Newsdesk
Earnings Scheduled For November 7, 2023
Benzinga Insights
Monday, November 06, 2023
Earnings Outlook For Personalis
Benzinga Insights
Thursday, October 26, 2023
Personalis Launches NeXT Personal Dx For Earl...
Benzinga Newsdesk
Sunday, October 22, 2023
Personalis On Saturday Announced Analysis From TRACERx Study Reveals More Sensitive And Earlier ctDNA Detection In Lung Cancer Patients By Personalis' MRD Technology
Charles Gross
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
